Cargando…
Development of a multi-gene-based immune prognostic signature in ovarian Cancer
BACKGROUND: Various components of the immune system play a critical role in the prognosis and treatment response in ovarian cancer (OC). Immunotherapy has been recognized as a hallmark of cancer but the effect is contradictional. Reliable immune gene-based prognostic biomarkers or regulatory factors...
Autores principales: | Cao, Tiefeng, Shen, Huimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844906/ https://www.ncbi.nlm.nih.gov/pubmed/33509250 http://dx.doi.org/10.1186/s13048-021-00766-4 |
Ejemplares similares
-
Development and validation of an immune gene-set based Prognostic signature in ovarian cancer
por: Shen, Sipeng, et al.
Publicado: (2018) -
Identification of fatty acid signature to predict prognosis and guide clinical therapy in patients with ovarian cancer
por: Cao, Tiefeng, et al.
Publicado: (2022) -
Identification of a Prognostic Signature for Ovarian Cancer Based on the Microenvironment Genes
por: Huo, Xiao, et al.
Publicado: (2021) -
Comprehensive analysis of prognostic gene signatures based on immune infiltration of ovarian cancer
por: Yan, Shibai, et al.
Publicado: (2020) -
Development and verification of an immune‐related gene pairs prognostic signature in ovarian cancer
por: Zhang, Bao, et al.
Publicado: (2021)